...
首页> 外文期刊>Japanese journal of clinical oncology. >Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer
【24h】

Development and validation of nomograms for prediction of overall survival and cancer-specific survival of patients with Stage IV colorectal cancer

机译:术后阶段患者整体存活和癌症特异性存活率的载体探测和验证

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Surgical resection of patients with resectable Stage IV colorectal cancer (CRC) is regarded as first choice if possible. However, its influence on overall survival (OS) has not been thoroughly explored. In this study, we aimed to construct nomograms to help predict 1-, 3- and 5-year OS rate and colorectal cancer-specific survival (CCSS) rate. Methods: A total of 2996 cases who underwent primary and metastatic resection were selected in the study from surveillance, epidemiology and end results (SEER) database. About 48 Stage IV CRC patients after resection from the Fudan University Shanghai Cancer Center (FUSCC) were assigned as an independent external validation group. Log-rank and multivariate Cox regression analysis were used. The competing-risks model was used to estimate the cumulative incidence of death. Nomograms were built for prediction of OS and CCSS after surgical resection in patients with Stage IV CRC. Results: The 1-, 3- and 5-year probabilities of OS were 76.6%, 41.4% and 23.2%, respectively. The 1-, 3- and 5-year colorectal cumulative incidence of death were 23.0%, 54.9% and 71.3%, respectively. The calibration curves for probability of 1-, 3- and 5-year OS and CCSS showed optimal agreement between nomogram prediction and actual observation, and the Harrell's C-indexes for the nomograms to predict OS and CCSS were 0.662 and 0.650, respectively. For FUSCC validation set, the C-index for this model to predict OS was 0.657. Conclusion: Nomograms for prediction of OS and CCSS of patients with Stage IV CRC who underwent primary and metastatic resection were built. Performance of the model was excellent. These nomograms may be helpful for patients and physicians when making a decision.
机译:背景:如果可能的话,可重症阶段IV结直肠癌(CRC)的患者的手术切除术称为首选。但是,它对整体生存(OS)的影响尚未彻底探索。在这项研究中,我们旨在构建载体图以帮助预测1-,3-岁和5年的OS率和结肠直肠癌特异性存活(CCSS)率。方法:从监测,流行病学和最终结果(SEER)数据库的研究中,共选出2996例接受初级和转移切除的病例。大约48阶段IV阶段CRC患者从复旦大学上海癌症中心(FUSCC)分配为独立的外部验证组。使用日志秩和多变量COX回归分析。竞争风险模型用于估计死亡的累积发病率。建立了术后IV CRC患者手术切除后的OS和CCS的载体和CCS。结果:OS的1-,3-和5年概率分别为76.6%,41.4%和23.2%。 1-,3-和5年结直肠癌的死亡发生率分别为23.0%,54.9%和71.3%。概率为1-,3-和5年的OS和CCS的校准曲线显示了NOM图预测和实际观察之间的最佳协议,并且哈尔尔的用于预测OS和CCSS的C指数分别为0.662和0.650。对于FUSCC验证集,此模型的C索引为预测OS为0.657。结论:建立了术后阶段IV阶段CRC患者OS和CCS的NOMA图。该模型的性能非常出色。在做出决定时,这些墨顶图可能对患者和医生有所帮助。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号